Literature DB >> 29722423

Mutations in mevalonate pathway genes in patients with familial or sporadic porokeratosis.

Yunji Leng1, Lulu Yan1, Hongquan Feng2, Chen Chen1, Shusen Wang1, Yang Luo1, Lihua Cao1.   

Abstract

Porokeratosis comprises heterogeneous keratinization disorders that are characterized by one or more atrophic patches surrounded by a ridge-like cornoid lamella. In this study, we evaluated seven families affected by porokeratosis and five sporadic patients of the disease in a Chinese population. We performed Sanger sequencing of exons and flanking intron-exon boundaries of mevalonate pathway genes (MVD, MVK, PMVK and FDPS) and of SLC17A9. In five familial and three sporadic patients, we detected six variations, including four novel mutations (MVD c.1A>G; p.Met1?, c.916G>A; p.Ala306Thr, c.1013+1G>A, and PMVK c.65A>G; p.Lys22Arg) and two recurrent mutations (MVD c.746T>C; p.Phe249Ser, and MVK c.1028T>C; p.Leu343Pro). We then applied I-TASSER and iGEMDOCK to assess these variants for probable functional impacts. The findings of this study extend the mutation spectrum of porokeratosis and provide further evidence for the genetic basis of this disease.
© 2018 Japanese Dermatological Association.

Entities:  

Keywords:  zzm321990zzm321990MVDzzm321990zzm321990; zzm321990zzm321990MVKzzm321990zzm321990; zzm321990zzm321990PMVKzzm321990zzm321990; mutation; porokeratosis

Mesh:

Substances:

Year:  2018        PMID: 29722423     DOI: 10.1111/1346-8138.14343

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  6 in total

1.  Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.

Authors:  Lihi Atzmony; Young H Lim; Claire Hamilton; Jonathan S Leventhal; Annette Wagner; Amy S Paller; Keith A Choate
Journal:  J Am Acad Dermatol       Date:  2019-08-23       Impact factor: 11.527

2.  A preliminary study of peripheral T-cell subsets in porokeratosis patients with MVK or MVD variants.

Authors:  L Tao; Y K Huang; K X Yan; C H Li; L Shen; Z H Zhang
Journal:  Skin Health Dis       Date:  2021-12-16

3.  Mixed porokeratosis with a novel mevalonate kinase gene mutation: A case report.

Authors:  Hong-Jun Xu; Guang-Dong Wen
Journal:  World J Clin Cases       Date:  2022-05-16       Impact factor: 1.534

4.  Two Cases of Porokeratosis with MVD Mutations, in Association with Bullous Pemphigoid.

Authors:  Yuki Arisawa; Yasutoshi Ito; Kana Tanahashi; Yoshinao Muro; Tomoo Ogi; Takuya Takeichi; Masashi Akiyama
Journal:  Acta Derm Venereol       Date:  2021-03-31       Impact factor: 3.875

Review 5.  Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency.

Authors:  Frouwkje A Politiek; Hans R Waterham
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

6.  An unusual case of generalized hyperkeratotic and verrucous porokeratosis.

Authors:  Johann de Wet; Minette Swart; H Francois Jordaan; Johann W Schneider; Suzanne Mulder; Willem I Visser
Journal:  JAAD Case Rep       Date:  2020-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.